Discipline
Résultats 1-9 de 9
-
A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice
Frontiers in Immunology, Frontiers, 2023, 14, 1267279Compte-rendu et recension critique d'ouvragetexte intégral -
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
Cancers, MDPI, 2020, 12; 6, 1666Compte-rendu et recension critique d'ouvragetexte intégral -
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
Current Oncology, MDPI, 2022, 29; 12, 9255-9270Compte-rendu et recension critique d'ouvragetexte intégral -
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
The Lancet, Elsevier, 01-2021, 397; 10272, 375-386Compte-rendu et recension critique d'ouvragetexte intégral -
Is the survival of patients treated with ipilimumab affected by antibiotics? An analysis of 1585 patients from the French National hospital discharge summary database (PMSI)
Oncoimmunology, Taylor & Francis, 2020, 9; 1, 1846914Compte-rendu et recension critique d'ouvragetexte intégral -
LBA65 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (MPM): 3-year update from CheckMate 743
Annals of Oncology, Elsevier, 09-2021, 32, S1341-S1342Compte-rendu et recension critique d'ouvrage -
Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function
Immunobiology, Elsevier, 2021, 226; 1, 152031Compte-rendu et recension critique d'ouvragetexte intégral -
Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma
International Journal of Molecular Sciences, MDPI, 2020, 21; 12, 4292Compte-rendu et recension critique d'ouvragetexte intégral -
Photodynamic Therapy Using a New Folate Receptor-Targeted Photosensitizer on Peritoneal Ovarian Cancer Cells Induces the Release of Extracellular Vesicles with Immunoactivating Properties
Journal of clinical medicine, MDPI, 2020, 9; 4, 1185Compte-rendu et recension critique d'ouvragetexte intégral